Prevalence And Determinants Of Hypertension Control Among Almost 100 000 Treated Adults In The UK

Open Heart. 2021; 8(1): e001461.

Published online 2021 Mar 11. doi: 10.1136/openhrt-2020-001461

Neo Tapela,1,2Jennifer Collister,1Lei Clifton,1Iain Turnbull,1Kazem Rahimi,3 and David J Hunter1

Abstract

Objective

To identify factors associated with hypertension control among treated middle-aged UK adults.

Methods

A cross-sectional population-based study including 99 468 previously diagnosed, treated hypertensives enrolled in the UK Biobank. Hypertension control was defined as systolic blood pressure <140 mm Hg and diastolic blood pressure <90 mm Hg.

Results

Median age was 62.3 years (IQR 57.3 to 66.0), 45.9% female, 92.0% white, 40.1% obese, 9.3% current smokers and 19.4% had prior cardiovascular disease. 38.1% (95% CI 37.8% to 38.4%) were controlled. In multivariable logistic regression, associations with lack of hypertension control included: older age (OR 0.61, 95% CI 0.58 to 0.64 for 60–69 years compared with age 40–50 years), higher alcohol use (OR 0.61, 95% CI 0.58 to 0.64, for consuming >30 units per week compared with none), black ethnicity (OR 0.73, 95% CI 0.65 to 0.82 compared with white), obesity (OR 0.73, 95% CI 0.71 to 0.76 compared with normal body mass index). The strongest positive association with control was having ≥3 comorbidities (OR 2.09, 95% CI 1.95 to 2.23). Comorbidities associated with control included cardiovascular disease (OR 2.11, 95% CI 2.04 to 2.19), migraines (OR 1.68, 95% CI 1.56 to 1.81), diabetes (OR 1.32, 95% CI 1.27 to 1.36) and depression (OR 1.27, 95% CI 1.20 to 1.34).

Conclusions

In one of the largest population-based analyses of middle-aged adults with measured blood pressure, the majority of treated hypertensives were uncontrolled. Risk factors for hypertension were associated with a lower probability of control. Having a comorbidity was associated with higher probability of control, possibly due to more frequent interaction with the healthcare system and/or appropriate management of those at greater cardiovascular risk.

Click here to read more.

Related Posts

124
Triglycerides: Why Do They Matter?
V2 (2)
Easter Delivery Schedule
FAHM-402 (2)
Anti-Müllerian Hormone Test
FAHM-402
What Is Anti-Mullerian Hormone Test?
< Back
There are no products in your cart.
Product total: €0.00
Pay now
0
0 items in your cart - €0.00
Pay now
Scroll to Top